Samuel Rogers

1.6k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Samuel Rogers is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Samuel Rogers has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cell Biology and 5 papers in Oncology. Recurrent topics in Samuel Rogers's work include Microtubule and mitosis dynamics (12 papers), DNA Repair Mechanisms (7 papers) and Cancer-related Molecular Pathways (5 papers). Samuel Rogers is often cited by papers focused on Microtubule and mitosis dynamics (12 papers), DNA Repair Mechanisms (7 papers) and Cancer-related Molecular Pathways (5 papers). Samuel Rogers collaborates with scholars based in Australia, United States and United Kingdom. Samuel Rogers's co-authors include Andrew Burgess, Rachael A. McCloy, C. Elizabeth Caldon, Thierry Lorca, Anna Castro, Anthony J. Cesare, Noa Lamm, D. Neil Watkins, Mina Rasouli and Benjamin L. Parker and has published in prestigious journals such as Cell, Nature Communications and Oncogene.

In The Last Decade

Samuel Rogers

20 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Partial inhibition of Cdk1 in G₂phase overrides the SAC and decouples mitotic events

2014 704 citations Rachael A. McCloy, Samuel Rogers et al. Cell Cycle profile →

Peers

Countries citing papers authored by Samuel Rogers

Since Specialization

Citations

This map shows the geographic impact of Samuel Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Rogers more than expected).

Fields of papers citing papers by Samuel Rogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Rogers. The network helps show where Samuel Rogers may publish in the future.

Co-authorship network of co-authors of Samuel Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Rogers. A scholar is included among the top collaborators of Samuel Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Rogers. Samuel Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A CPC-shelterin-BTR axis regulates mitotic telomere deprotection 2025 ·Nature Communications ·(unknown), Samuel Rogers, Ronnie Ren Jie Low, (unknown), (unknown), (unknown), (unknown), (unknown), Noa Lamm, Fuyuki Ishikawa, Makoto Hayashi, Anthony J. Cesare	1
2	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation 2024 ·Nature Communications ·Christopher B. Nelson, Samuel Rogers, (unknown), Yaw Sing Tan, (unknown), Alexander P. Sobinoff, Christopher G. Tomlinson, (unknown), Robert Lu, Eloïse Dray, Michelle Haber, Jamie I. Fletcher, Anthony J. Cesare, Rashmi S. Hegde, Hilda A. Pickett	4
3	Distinct modes of telomere synthesis and extension contribute to Alternative Lengthening of Telomeres 2023 ·iScience ·Robert Lu, Christopher B. Nelson, Samuel Rogers, Anthony J. Cesare, Alexander P. Sobinoff, Hilda A. Pickett	9
4	SILAC kinase screen identifies potential MASTL substrates 2022 ·Scientific Reports ·(unknown), Samuel Rogers, Rachael A. McCloy, Benjamin L. Parker, David E. James, D. Neil Watkins, Andrew Burgess	4
5	BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer 2021 ·Clinical Epigenetics ·Katherine A. Giles, Cathryn M. Gould, Joanna Achinger-Kawecka, (unknown), Georgia R. Kafer, Samuel Rogers, Phuc‐Loi Luu, Anthony J. Cesare, Susan J. Clark, Phillippa C. Taberlay	18
6	Chromatin mobility and relocation in DNA repair 2021 ·Trends in Cell Biology ·Noa Lamm, Samuel Rogers, Anthony J. Cesare	39
7	Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer 2020 ·Cancers ·Christine U. Lee, Kristine J. Fernandez, Sarah Alexandrou, C. Marcelo Sergio, Niantao Deng, Samuel Rogers, Andrew Burgess, C. Elizabeth Caldon	18
8	The mTOR pathway: Implications for DNA replication 2019 ·Progress in Biophysics and Molecular Biology ·Noa Lamm, Samuel Rogers, Anthony J. Cesare	33
9	MASTL overexpression promotes chromosome instability and metastasis in breast cancer 2018 ·Oncogene ·Samuel Rogers, Rachael A. McCloy, Benjamin L. Parker, David Gallego‐Ortega, Andrew M. K. Law, Venessa Chin, James R. W. Conway, Dirk Fey, Ewan K.A. Millar, Sandra O’Toole, Niantao Deng, Alexander Swarbrick, Paul D. Chastain, Anthony J. Cesare, Paul Timpson, C. Elizabeth Caldon, David R. Croucher, David E. James, D. Neil Watkins, Andrew Burgess	42
10	SnapShot: Phosphoregulation of Mitosis 2017 ·Cell ·Andrew Burgess, (unknown), Samuel Rogers, Marcos Malumbres, Séan O’Donoghue	11
11	The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer 2017 ·Oncogene ·Anette Szczepny, Samuel Rogers, W. Samantha N. Jayasekara, (unknown), Rachael A. McCloy, Catherine R. Cochrane, Vinod Ganju, Wendy A. Cooper, Julien Sage, Craig D. Peacock, Jason E. Cain, Andrew Burgess, D. Neil Watkins	52
12	Andy’s Algorithms: new automated digital image analysis pipelines for FIJI 2017 ·Scientific Reports ·Andrew M. K. Law, Julia Yin, Lesley Castillo, Adelaide I.J. Young, Catherine Piggin, Samuel Rogers, Catherine E Caldon, Andrew Burgess, Ewan K.A. Millar, Sandra A. O’Toole, David Gallego‐Ortega, Christopher J. Ormandy, Samantha R. Oakes	37
13	Mechanisms regulating phosphatase specificity and the removal of individual phosphorylation sites during mitotic exit 2016 ·BioEssays ·Samuel Rogers, Rachael A. McCloy, D. Neil Watkins, Andrew Burgess	20
14	PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells 2016 ·Journal of Cell Science ·Samuel Rogers, Dirk Fey, Rachael A. McCloy, Benjamin L. Parker, Nicholas J. Mitchell, Richard J. Payne, Roger J. Daly, David E. James, C. Elizabeth Caldon, D. Neil Watkins, David R. Croucher, Andrew Burgess	43
15	An objective measure for the visual fidelity of virtual reality and the risks of falls in a virtual environment 2016 ·Virtual Reality ·Rosemary J. Menzies, Samuel Rogers, Anastasia Phillips, Elodie Chiarovano, Catherine de Waele, Frans A.J. Verstraten, Hamish G. MacDougall	37
16	Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells 2015 ·Cell Division ·Samuel Rogers, Brian Gloss, (unknown), C. Marcelo Sergio, Marcel E. Dinger, Elizabeth A. Musgrove, Andrew Burgess, Catherine E Caldon	19
17	Global Phosphoproteomic Mapping of Early Mitotic Exit in Human Cells Identifies Novel Substrate Dephosphorylation Motifs 2015 ·Molecular & Cellular Proteomics ·Rachael A. McCloy, Benjamin L. Parker, Samuel Rogers, Rima Chaudhuri, Velimir Gayevskiy, Nolan J. Hoffman, Naveid Ali, D. Neil Watkins, Roger J. Daly, David E. James, Thierry Lorca, Anna Castro, Andrew Burgess	58
18	Dataset from the global phosphoproteomic mapping of early mitotic exit in human cells 2015 ·Data in Brief ·Samuel Rogers, Rachael A. McCloy, Benjamin L. Parker, Rima Chaudhuri, Velimir Gayevskiy, Nolan J. Hoffman, D. Neil Watkins, Roger J. Daly, David E. James, Andrew Burgess	5
19	Partial inhibition of Cdk1 in G₂phase overrides the SAC and decouples mitotic events breakdown → 2014 ·Cell Cycle ·Rachael A. McCloy, Samuel Rogers, C. Elizabeth Caldon, Thierry Lorca, Anna Castro, Andrew Burgess	704
20	Stressing Mitosis to Death 2014 ·Frontiers in Oncology ·Andrew Burgess, Mina Rasouli, Samuel Rogers	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact